Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Breast Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Endometrial Neoplasms 3Urogenital Neoplasms 2Prostatic Neoplasms 2Brain Neoplasms 2Pancreatic Ductal Adenocarcinoma 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Anus Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Genetic Testing × Gastrointestinal × Clear all
NCT00899002 2013-04-10

Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer

Vanderbilt-Ingram Cancer Center

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡